November 4, 2015—The rising cost of prescription drugs is reaching critical mass at the federal level, with a Senate committee today announcing a bipartisan investigation, top House Democrats today announcing a task force, and the Department of Health and Human Services yesterday announcing a daylong summit later this month.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)